Capital Ideas Radio

Episode 047 - Ken d’Entrecote, CEO, Medexus Pharmaceuticals

November 11, 2019

Investors have a compelling, low-risk, specialty pharmaceutical company under their noses they may not know about. Capital Ideas Media president and publisher Mark Bunting sits down with Ken d’Entremont, CEO of Medexus Pharmaceuticals (TSXV:MDP), to find out about the company’s model of licensing existing drugs, its fast-growing revenue and operating profit, and how close the firm is to making a transformational deal using its $27 million in cash.

Play this podcast on Podbean App